ECOR electrocore.com: מקדם חוב לטווח ארוך להון

electroCore, Inc. (ECOR) generates revenue from the supply of non-invasive devices for the treatment of cluster headaches and migraines. The current level of long-term financial dependence reflects borrowing dynamics where the status is 0.00. Regular sales of gammaCore activation cards ensure business stability, creating a predictable cash flow. The company's growth relies on expanding distribution through US Veterans Affairs hospitals to scale profits.

Conservative capital demands absolute transparency regarding debt load to assess the issuer's financial stability. This metric measures the proportion of liabilities with a maturity exceeding one year relative to the market value of equity. A steady cash flow from the sale of medical stimulators minimizes liquidity gap risks for electroCore, Inc. (ECOR). By analyzing the long-term debt-to-equity coverage ratio, an investor can see the current impact of borrowings on the business value. The trend in the long-term debt-to-equity coverage ratio allows for the prompt adjustment of portfolio structure.